Key Takeaways
- Fluconazole is a prescription oral antifungal taken as a single 150 mg dose for uncomplicated vaginal yeast infection.[2]
- It clears most uncomplicated infections, with cure rates comparable to topical azoles.[6]
- It blocks an enzyme (CYP51) the fungus needs for its cell membrane, and oral dosing reaches the bloodstream, treating Candida systemically.[1]
- Weekly 150 mg fluconazole is the classic maintenance therapy for recurrent infections, keeping about 91 percent of women episode-free over six months.[7]
- It is avoided in pregnancy and carries drug interactions with warfarin, some statins, and other medicines.[1]
- When fluconazole no longer works, the cause is often fluconazole resistance or a non-albicans species such as C. glabrata.[8]
For many people, a single pill is the simplest way to clear a yeast infection, and that pill is almost always fluconazole. This guide explains what fluconazole is, how it works, how well it works, its real safety considerations, and what to do when it stops working.
What Is Fluconazole
Fluconazole is a systemic azole antifungal, best known by the brand name Diflucan. It was introduced in the early 1990s and has been available as an inexpensive generic for years. For vaginal candidiasis it is used as a single 150 mg oral dose, a regimen that makes treating an uncomplicated infection a one-tablet event.[1][2]
Because it is oral, fluconazole requires a prescription in the United States, in contrast to the topical azoles miconazole, clotrimazole, and tioconazole, which are available over the counter.[2]
How It Works
Azole antifungals work by blocking an enzyme called lanosterol 14-alpha-demethylase (CYP51). This enzyme is required for the fungus to make ergosterol, the essential building block of its cell membrane. Blocking it makes the fungal membrane leaky and unstable, which stops the fungus from growing and replicating.[1][3]
Fluconazole is absorbed well after swallowing and distributes throughout the body, including into vaginal tissue and secretions. Because of its long half-life, one dose produces levels that remain high enough to treat the infection for several days, which is why a single tablet suffices for an uncomplicated episode.[1]
Dosing for Yeast Infection
- Uncomplicated infection: a single 150 mg oral dose.[2]
- Severe infection: fluconazole 150 mg every 72 hours for two doses (or topical therapy for 7 to 14 days), per CDC guidance.[2]
- Recurrent infection suppression: after clearing the acute episode, fluconazole 150 mg once weekly for six months, the regimen validated in the landmark NEJM trial.[7]
Fluconazole can be taken with or without food, and a single dose does not require a loading or refill schedule for an uncomplicated case.[1]
Fluconazole Dosing by Scenario
| Scenario | Regimen | Note |
|---|---|---|
| Uncomplicated infection | 150 mg once | Standard single-tablet regimen[2] |
| Severe infection | 150 mg every 72 hours for two doses | Or a 7 to 14 day topical course[2] |
| Recurrent suppression | 150 mg once weekly for 6 months | After induction of the current episode[7] |
| Pregnancy | Avoided | Use a topical azole for 7 days instead[1] |
Effectiveness
For uncomplicated vulvovaginal candidiasis, a single 150 mg dose of fluconazole produces clinical and mycologic cure in the large majority of women. A 2015 study reported high mycologic cure rates with single-dose fluconazole for acute infection, and randomized comparisons going back decades have found it roughly equivalent to a full course of topical therapy.[5][4]
A 2025 review concluded oral and topical treatment achieve similar outcomes for uncomplicated infection, with the choice driven mainly by convenience and preference.[6]
Fluconazole vs Topical Azoles
| Attribute | Oral fluconazole 150 mg | Topical azole (clotrimazole, miconazole) |
|---|---|---|
| Route / dosing | One oral tablet, single dose | Vaginal cream or suppository, 1 to 7 days |
| Availability | Prescription | Over the counter (except terconazole) |
| Effectiveness | Comparable, roughly 85 to 95 percent cure[6] | Comparable[6] |
| Convenience | Highest (one pill) | Lower (nightly application) |
| Systemic exposure | Yes (whole body) | No (local only) |
| In pregnancy | Avoided[1] | Recommended (7-day course)[2] |
| Drug interactions | Several[1] | Minimal |
| Local irritation | None | Possible burning at application site |
The convenience of a single pill is the main reason people choose fluconazole; the avoidance of systemic exposure and drug interactions is the main reason they choose a topical. Both are appropriate first choices for uncomplicated infection.[6]
Side Effects
Fluconazole is generally well tolerated in single-dose use. The most common side effects are headache, nausea, abdominal pain, and diarrhea, usually mild and short-lived.[1] Less commonly it can raise liver enzymes, and rare serious reactions are possible with higher or prolonged dosing. Because a yeast-infection course is a single dose, the exposure and therefore the risk is minimal for most healthy adults.[1]
One important caution: a small number of people experience a skin rash; serious allergic skin reactions are rare. If you develop a rash, blistering, or swelling after taking fluconazole, stop and seek care.[1]
Drug Interactions
Fluconazole inhibits liver enzymes (CYP2C9, CYP2C19, and CYP3A4) that process many other medicines, so it can raise the levels of those drugs. Clinically important interactions include:[1]
- Warfarin (increased bleeding risk)
- Certain statins such as atorvastatin and simvastatin (muscle injury risk)
- Some heart-rhythm medicines and QT-prolonging drugs
- Several anti-seizure drugs and oral hypoglycemics
Always tell your prescriber about every medicine and supplement you take before a course of fluconazole, even a single dose.[1]
Notable Drug Interactions
| Medicine | Concern |
|---|---|
| Warfarin | Increased bleeding risk |
| Certain statins (atorvastatin, simvastatin) | Risk of muscle injury |
| QT-prolonging and heart-rhythm medicines | Irregular heart rhythm risk |
| Some anti-seizure drugs and oral hypoglycemics | Altered drug levels |
Pregnancy and Breastfeeding
Fluconazole is generally avoided in pregnancy, especially in the first trimester, because higher or repeated doses have been associated with a possible increased risk of certain birth defects, and a single dose also carries caution.[1] For yeast infection in pregnancy, the CDC recommends a topical azole such as clotrimazole or miconazole for seven days instead.[2] Among topical options studied in pregnancy, sertaconazole has also been shown effective and well tolerated.[11]
Fluconazole passes into breast milk. A single 150 mg dose is generally considered compatible with breastfeeding by most sources, but always discuss it with your clinician, and lactating people should follow their provider's guidance.[1]
Fluconazole for Recurrent Infection
For women with recurrent infection (four or more episodes a year), fluconazole has a second, long-standing role as maintenance therapy. After clearing the current episode, a 150 mg dose once weekly for six months dramatically reduces relapses. In the landmark 2004 National trial by Sobel and colleagues, 90.8 percent of women on weekly fluconazole remained recurrence-free at six months, versus 35.9 percent on placebo, and the median time to the next episode stretched from 4.0 months to 10.2 months. The protective effect lasts only while taking the drug; after stopping, rates converge again.[7]
For women who relapse despite weekly fluconazole, newer options such as oteseconazole and monthly ibrexafungerp now exist, covered in the recurrent yeast infection guide.[12][9]
When Fluconazole Fails
If a yeast infection does not clear with fluconazole, or returns quickly, the two leading explanations are:
- A non-albicans species. Candida glabrata and Candida krusei are frequently less susceptible to fluconazole. Culture with susceptibility testing identifies the species and guides the switch.[8]
- Acquired fluconazole resistance in C. albicans, which has been reported with increasing frequency, particularly with repeated exposure.[8]
Alternatives include topical azoles that remain effective against some resistant strains, boric acid vaginal capsules, and the newer oral agents ibrexafungerp and oteseconazole.[8][10]
Cost and Access
Fluconazole is inexpensive as a generic, typically a few dollars for a single 150 mg tablet at most pharmacies, which is often less than the cost of a multi-day over-the-counter topical course. It requires a prescription, which can be obtained from an in-person clinician or through a synchronous telehealth visit in all 50 U.S. states. Many insurance plans and discount programs cover the generic with little or no copay.[2]
Red Flags
Seek care if a yeast infection does not improve within several days of fluconazole, if symptoms recur quickly, if you are pregnant, if you develop a rash or swelling after the dose, or if you have unexplained fever, pelvic pain, or new discharge. These may indicate resistance, a different diagnosis, or a drug reaction.[8]
Frequently Asked Questions
Many people notice improvement within 24 hours and substantial relief within two to three days, with full clearing of symptoms typically within a week. If there is no improvement in three days, contact your clinician.[5]
For an uncomplicated infection, yes, a single 150 mg dose is the standard regimen and clears the majority of cases. Severe or recurrent infections need additional or repeated dosing.[2]
No. Fluconazole requires a prescription in the United States. Over-the-counter products for yeast are the topical azoles (miconazole, clotrimazole, tioconazole), not oral fluconazole.[2]
Headache, nausea, abdominal pain, and diarrhea are most common and usually mild. Serious reactions are rare with a single dose. Report any rash, blistering, or facial swelling promptly.[1]
A single dose and modest alcohol intake are generally not a major interaction, but alcohol can add to nausea. Because fluconazole is processed by the liver, it is wise to keep alcohol minimal around the time of a dose, especially with any liver condition.[1]
The most common reasons are a non-albicans species such as Candida glabrata that is less susceptible to fluconazole, acquired fluconazole resistance, or a different diagnosis altogether. Culture with susceptibility testing can clarify.[8]
Yes, weekly 150 mg fluconazole for six months is the classic maintenance therapy, keeping about 91 percent of women free of recurrence during treatment. The benefit lasts only while taking the medication.[7]
Fluconazole does not significantly reduce the effectiveness of most hormonal contraceptives, but because it affects liver enzymes, combined pills may rarely cause slightly higher hormone levels. Routine contraceptive effectiveness is generally maintained; mention all medicines to your prescriber.[1]
Yes. Diflucan is the brand name for fluconazole. The generic fluconazole is chemically identical and far less expensive, and is what most pharmacies dispense today.[1]
References
- U.S. Food and Drug Administration. Diflucan (fluconazole) prescribing information. FDA label
- Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187. doi:10.15585/mmwr.rr7004a1
- Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1-e50. doi:10.1093/cid/civ933
- Slavin MB, Benrubi GI, Parker R, Griffin CR. Single dose oral fluconazole vs intravaginal terconazole in treatment of Candida vaginitis. J Fla Med Assoc. 1992;79(10):693-696. PMID 1460451
- Mikamo H, Matsumizu M, Nakazuru Y, Okayama A. Efficacy and safety of a single oral 150 mg dose of fluconazole for the treatment of vulvovaginal candidiasis. J Infect Chemother. 2015;21(9):652-656. doi:10.1016/j.jiac.2015.03.011
- Gardella B, Dominoni M, Cassani C, et al. Treatment of uncomplicated vulvovaginal candidiasis: topical or oral drugs? Am J Obstet Gynecol. 2025. doi:10.1016/j.ajog.2025.03.031
- Sobel JD, Wiesenfeld HC, Martens M, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med. 2004;351(9):876-883. doi:10.1056/NEJMoa033114
- Akinosoglou K, Livieratos A, Asimos K, et al. Fluconazole-Resistant Vulvovaginal Candidosis: An Update on Current Management. Pharmaceutics. 2024;16(12):1555. doi:10.3390/pharmaceutics16121555
- Goje O, Azie NE, Angulo DA, et al. A phase 3, multicenter, randomized, placebo-controlled trial of monthly oral ibrexafungerp for the prevention of recurrent vulvovaginal candidiasis (CANDLE). Am J Obstet Gynecol. 2025. doi:10.1016/j.ajog.2025.07.040
- Schwebke JR, Sobel R, Gersten JK, et al. Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303). Clin Infect Dis. 2022;74(11):1979-1985. doi:10.1093/cid/ciab750
- Chayachinda C, Thamkhantho M, Rekhawasin T, Klerdklinhom C. Sertaconazole 300 mg versus clotrimazole 500 mg vaginal suppository for treating vulvovaginal candidiasis in pregnant women: a randomized controlled trial. BMC Pregnancy Childbirth. 2024;24. doi:10.1186/s12884-024-06440-z
- Sobel JD, Donders G, Degenhardt T, et al. Efficacy and Safety of Oteseconazole in Recurrent Vulvovaginal Candidiasis. NEJM Evid. 2022;1(8):EVIDoa2100055. doi:10.1056/EVIDoa2100055